Evidence-Based Medicine Guidelines
Parenteral anticoagulation in ambulatory patients with cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Parenteral Anticoagulation in Ambulatory Patients With Cancer." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/456909/all/Parenteral_anticoagulation_in_ambulatory_patients_with_cancer.
Parenteral anticoagulation in ambulatory patients with cancer. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/456909/all/Parenteral_anticoagulation_in_ambulatory_patients_with_cancer. Accessed October 8, 2024.
Parenteral anticoagulation in ambulatory patients with cancer. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/456909/all/Parenteral_anticoagulation_in_ambulatory_patients_with_cancer
Parenteral Anticoagulation in Ambulatory Patients With Cancer [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 October 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/456909/all/Parenteral_anticoagulation_in_ambulatory_patients_with_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Parenteral anticoagulation in ambulatory patients with cancer
ID - 456909
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/456909/all/Parenteral_anticoagulation_in_ambulatory_patients_with_cancer
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
